Medical Devices & Surgical Technology Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices & Surgical Technology Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business Update
Korean NIH, Affymetrix to collaborate to identify genes associated with critical diseases
April 11th, 2006
Affymetrix Inc. (AFFX) announced that Korean National Institute of Health (NIH) and Center for Disease Control and Prevention will use the Affymetrix GeneChip Human Mapping 500K Array Set for a series of genome-wide association studies in critical disease areas, including diabetes, hypertension, asthma and metabolic syndrome. The Korean NIH will work with its academic and industry collaborators to generate more than 10 billion individual genotypes from 20,000 human DNA samples to help identify the genetic causes of these diseases. Until recently, scientists have had a difficult time performing whole-genome association studies in complex diseases...
Source: Medical Devices & Surgical Technology Week (2006-04-11)
|
